← Back to Search

SPHERE for Migraine

N/A
Waitlist Available
Led By Anna Huguet, PhD
Research Sponsored by IWK Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline and at 4-months post-randomization
Awards & highlights

Study Summary

This randomized controlled trial will compare the effectiveness of two online self-guided programs for youth and young adults with migraine against usual care.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline and at 4-months post-randomization
This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline and at 4-months post-randomization for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Clinically significant improvement (50% reduction or greater) in number of headache days in a 4-week period from baseline to 4-months post-randomization
Secondary outcome measures
Therapeutic procedure
Statistically significant improvement in depressive symptomatology from baseline to 4-months post-randomization.
Statistically significant improvement in headache-related functional impairment from baseline to 4-months post-randomization
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: SPHEREExperimental Treatment1 Intervention
It is an online self-guided comprehensive cognitive-behavioural therapy program that offers a headache diary, learning modules that teach a variety of cognitive and behavioural skills to cope better with their headaches, and a discussion forum where users may interact.
Group II: PRISMExperimental Treatment1 Intervention
It is an online self-guided brief cognitive-behavioural therapy program that offers a headache diary and helps users discover their headache triggers and non-triggers. Then the program provides the users with a few personalized recommendations to help them to cope with their triggers.
Group III: Usual careActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PRISM
2016
N/A
~170
SPHERE
2016
N/A
~60

Find a Location

Who is running the clinical trial?

Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,345 Previous Clinical Trials
26,453,090 Total Patients Enrolled
IWK Health CentreLead Sponsor
125 Previous Clinical Trials
100,049 Total Patients Enrolled
1 Trials studying Migraine
60 Patients Enrolled for Migraine
Nova Scotia Health Research FoundationOTHER_GOV
14 Previous Clinical Trials
33,628 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Testing myWHI: Online Self-help Programs for Headaches
Anna Huguet 2018. "Testing myWHI: Online Self-help Programs for Headaches". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03504150.
All > Headache
~61 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top